Literature DB >> 31406382

Placental growth factor regulates the generation of TH17 cells to link angiogenesis with autoimmunity.

Seung-Ah Yoo1,2, Mingyo Kim3,4, Min-Cheol Kang5, Jin-Sun Kong1,2, Ki-Myo Kim1,2, Saseong Lee1,2, Bong-Ki Hong1,2, Gi Heon Jeong1,2, Jinhee Lee5, Min-Gyeong Shin6, Yeon-Gu Kim6, Ivana Apicella7, Valeria Cicatiello7, Sandro De Falco7, Chong-Hyeon Yoon1,8, Chul-Soo Cho1,8, Zae Young Ryoo9, Seung-Hyo Lee10, Wan-Uk Kim11,12,13.   

Abstract

Helper T cells actively communicate with adjacent cells by secreting soluble mediators, yet crosstalk between helper T cells and endothelial cells remains poorly understood. Here we found that placental growth factor (PlGF), a homolog of the vascular endothelial growth factor that enhances an angiogenic switch in disease, was selectively secreted by the TH17 subset of helper T cells and promoted angiogenesis. Interestingly, the 'angio-lymphokine' PlGF, in turn, specifically induced the differentiation of pathogenic TH17 cells by activating the transcription factor STAT3 via binding to its receptors and replaced the activity of interleukin-6 in the production of interleukin-17, whereas it suppressed the generation of regulatory T cells. Moreover, T cell-derived PlGF was required for the progression of autoimmune diseases associated with TH17 differentiation, including experimental autoimmune encephalomyelitis and collagen-induced arthritis, in mice. Collectively, our findings provide insights into the PlGF-dictated links among angiogenesis, TH17 cell development and autoimmunity.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31406382     DOI: 10.1038/s41590-019-0456-4

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  3 in total

1.  A placenta growth factor 2 variant acts as dominant negative of vascular endothelial growth factor A by heterodimerization mechanism.

Authors:  Valeria Tarallo; Laura Tudisco; Sandro De Falco
Journal:  Am J Cancer Res       Date:  2010-12-21       Impact factor: 6.166

2.  Peripheral blood T lymphocytes and lymphocytes infiltrating human cancers express vascular endothelial growth factor: a potential role for T cells in angiogenesis.

Authors:  M R Freeman; F X Schneck; M L Gagnon; C Corless; S Soker; K Niknejad; G E Peoples; M Klagsbrun
Journal:  Cancer Res       Date:  1995-09-15       Impact factor: 12.701

3.  Role of STAT3 in regulatory T lymphocyte plasticity during acute graft-vs.-host-disease.

Authors:  Masayuki Fujino; Xiao-Kang Li
Journal:  JAKSTAT       Date:  2013-04-16
  3 in total
  19 in total

1.  Dynamic transcriptome analysis unveils key proresolving factors of chronic inflammatory arthritis.

Authors:  Jin-Sun Kong; Ji-Hwan Park; Seung-Ah Yoo; Ki-Myo Kim; Yeung-Jin Bae; Yune-Jung Park; Chul-Soo Cho; Daehee Hwang; Wan-Uk Kim
Journal:  J Clin Invest       Date:  2020-08-03       Impact factor: 14.808

Review 2.  Cytokines and transcription factors in the differentiation of CD4+ T helper cell subsets and induction of tissue inflammation and autoimmunity.

Authors:  Mathias Pawlak; Allen W Ho; Vijay K Kuchroo
Journal:  Curr Opin Immunol       Date:  2020-10-08       Impact factor: 7.486

3.  Lymph node fibroblastic reticular cells regulate differentiation and function of CD4 T cells via CD25.

Authors:  Dongeon Kim; Mingyo Kim; Tae Woo Kim; Yong-Ho Choe; Hae Sook Noh; Hyun Min Jeon; HyunSeok Kim; Youngeun Lee; Gayeong Hur; Kyung-Mi Lee; Kihyuk Shin; Sang-Il Lee; Seung-Hyo Lee
Journal:  J Exp Med       Date:  2022-03-22       Impact factor: 14.307

4.  Safety, recommended dose, efficacy and immune correlates for nintedanib in combination with pembrolizumab in patients with advanced cancers.

Authors:  Capucine Baldini; Francois-Xavier Danlos; Andreea Varga; Matthieu Texier; Heloise Halse; Severine Mouraud; Lydie Cassard; Stéphane Champiat; Nicolas Signolle; Perrine Vuagnat; Patricia Martin-Romano; Jean-Marie Michot; Rastislav Bahleda; Anas Gazzah; Lisa Boselli; Delphine Bredel; Jonathan Grivel; Chifaou Mohamed-Djalim; Guillaume Escriou; Laetitia Grynszpan; Amelie Bigorgne; Saloomeh Rafie; Alae Abbassi; Vincent Ribrag; Sophie Postel-Vinay; Antoine Hollebecque; Sandrine Susini; Siham Farhane; Ludovic Lacroix; Aurelien Parpaleix; Salim Laghouati; Laurence Zitvogel; Julien Adam; Nathalie Chaput; Jean-Charles Soria; Christophe Massard; Aurelien Marabelle
Journal:  J Exp Clin Cancer Res       Date:  2022-07-07

Review 5.  Role of Cytokines and Chemokines in Angiogenesis in a Tumor Context.

Authors:  Mannon Geindreau; Mélanie Bruchard; Frédérique Vegran
Journal:  Cancers (Basel)       Date:  2022-05-16       Impact factor: 6.575

6.  Connecting angiogenesis and autoimmunity.

Authors:  Kirsty Minton
Journal:  Nat Rev Immunol       Date:  2019-10       Impact factor: 53.106

Review 7.  Angiogenesis and immune checkpoint dual blockade in combination with radiotherapy for treatment of solid cancers: opportunities and challenges.

Authors:  Lingling Zhu; Xianzhe Yu; Li Wang; Jiewei Liu; Zihan Qu; Honge Zhang; Lu Li; Jiang Chen; Qinghua Zhou
Journal:  Oncogenesis       Date:  2021-07-10       Impact factor: 7.485

8.  Angiogenic cytokines can reflect the synovitis severity and treatment response to biologics in rheumatoid arthritis.

Authors:  Ji-Won Kim; Jin-Sun Kong; Saseong Lee; Seung-Ah Yoo; Jung Hee Koh; Jingchun Jin; Wan-Uk Kim
Journal:  Exp Mol Med       Date:  2020-05-27       Impact factor: 8.718

Review 9.  PlGF Immunological Impact during Pregnancy.

Authors:  Loredana Albonici; Monica Benvenuto; Chiara Focaccetti; Loredana Cifaldi; Martino Tony Miele; Federica Limana; Vittorio Manzari; Roberto Bei
Journal:  Int J Mol Sci       Date:  2020-11-18       Impact factor: 5.923

Review 10.  T Cells in Autoimmunity-Associated Cardiovascular Diseases.

Authors:  Daniella Muallem Schwartz; Aarohan M Burma; Moses M Kitakule; Yiming Luo; Nehal N Mehta
Journal:  Front Immunol       Date:  2020-10-07       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.